López‐Torres, M. O., Marquina‐Castillo, B., Ramos‐Espinosa, O., Mata‐Espinosa, D., Barrios‐Payan, J. A., Baay‐Guzman, G., . . . Hernández‐Pando, R. (2021). 16α‐Bromoepiandrosterone as a new candidate for experimental diabetes–tuberculosis co‐morbidity treatment. Clinical and experimental immunology, 205(2), 232-245.
Chicago Style (17th ed.) CitationLópez‐Torres, Manuel Othoniel, et al. "16α‐Bromoepiandrosterone as a New Candidate for Experimental Diabetes–tuberculosis Co‐morbidity Treatment." Clinical and Experimental Immunology 205, no. 2 (2021): 232-245.
MLA (8th ed.) CitationLópez‐Torres, Manuel Othoniel, et al. "16α‐Bromoepiandrosterone as a New Candidate for Experimental Diabetes–tuberculosis Co‐morbidity Treatment." Clinical and Experimental Immunology, vol. 205, no. 2, 2021, pp. 232-245.
Visit our Citation Styles guide for help on properly citing sources.